World Cough Pipeline Review 2016 - 18 Companies & 26 Molecules - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Cough - Pipeline Review, H2 2016" report to their offering.

A cough is a common reflex action that aims to clear the throat of mucus or foreign irritants. Dry cough, chronic cough and whooping cough (also known as pertussis) are distinct types of cough. Symptoms include runny or stuffy nose, hoarseness, wheezing and shortness of breath, heartburn or a sour taste in mouth and rarely coughing up blood. The predisposing factors include asthma, chronic obstructive pulmonary disease, cigarette smoking, lung diseases such as bronchiectasis, interstitial lung disease, or tumors, lung infections such as pneumonia or acute bronchitis and allergic rhino sinusitis. Treatment includes cough suppressants, oral expectorants, and topical (externally applied) drugs.

Cough pipeline therapeutics constitutes close to 26 molecules. Out of which approximately 25 molecules are developed by Companies and remaining by the Universities/Institutes. The molecules developed by Companies in Phase III, Phase II, Preclinical, Discovery and Unknown stages are 3, 8, 10, 1 and 3 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 1 molecules, respectively.

Cough - Pipeline Review, H2 2016, outlays comprehensive information on the therapeutics under development for Cough, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews of key players involved in therapeutic development for Cough and features dormant and discontinued projects.

Key Topics Covered:

  1. Introduction
  2. Cough Overview
  3. Therapeutics Development
  4. Pipeline Products for Cough - Overview
  5. Pipeline Products for Cough - Comparative Analysis
  6. Cough - Therapeutics under Development by Companies
  7. Cough - Therapeutics under Investigation by Universities/Institutes
  8. Cough Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Cough - Products under Development by Companies
  13. Cough - Products under Investigation by Universities/Institutes
  14. Cough - Companies Involved in Therapeutics Development
  • Afferent Pharmaceuticals, Inc.
  • Alitair Pharmaceuticals, Inc.
  • Alveonix AG
  • AstraZeneca Plc
  • AusBio Ltd
  • Charleston Laboratories, Inc.
  • Conrig Pharma ApS
  • Daewoong Pharmaceutical Co., Ltd.
  • GlaxoSmithKline Plc
  • Glenmark Pharmaceuticals Ltd.
  • GW Pharmaceuticals Plc
  • Hyundai Pharmaceutical Co., Ltd.
  • Johnson & Johnson
  • NeRRe Therapeutics Ltd
  • Orbis Biosciences Inc
  • Patara Pharma, Inc.
  • Pila Pharma AB
  • Vernalis Plc

For more information about this report visit http://www.researchandmarkets.com/research/82trzt/cough_pipeline.

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Over the Counter (OTC) Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Over the Counter (OTC) Drugs